IRIS
GAGLIARDINI, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.248
NA - Nord America 1.946
AS - Asia 1.044
SA - Sud America 138
Continente sconosciuto - Info sul continente non disponibili 113
AF - Africa 83
OC - Oceania 5
Totale 5.577
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.888
IT - Italia 587
RU - Federazione Russa 446
SG - Singapore 373
GB - Regno Unito 320
CN - Cina 235
IE - Irlanda 230
DE - Germania 184
VN - Vietnam 161
BR - Brasile 115
SE - Svezia 113
FR - Francia 108
HK - Hong Kong 71
FI - Finlandia 69
IN - India 52
NL - Olanda 50
ZA - Sudafrica 40
UA - Ucraina 38
CA - Canada 32
KR - Corea 31
ES - Italia 24
BE - Belgio 20
TR - Turchia 20
AT - Austria 16
BD - Bangladesh 13
PL - Polonia 13
JP - Giappone 12
IQ - Iraq 11
MX - Messico 11
PK - Pakistan 10
UG - Uganda 10
AR - Argentina 9
ID - Indonesia 8
PT - Portogallo 8
CR - Costa Rica 6
ET - Etiopia 6
MA - Marocco 6
NG - Nigeria 6
PH - Filippine 6
KE - Kenya 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CL - Cile 4
CO - Colombia 4
JO - Giordania 4
LT - Lituania 4
BG - Bulgaria 3
LB - Libano 3
NP - Nepal 3
SA - Arabia Saudita 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EG - Egitto 2
EU - Europa 2
IR - Iran 2
LV - Lettonia 2
PA - Panama 2
QA - Qatar 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
SI - Slovenia 1
TH - Thailandia 1
UY - Uruguay 1
ZW - Zimbabwe 1
Totale 5.466
Salva come PNG Salva come JPEG
Città #
Southend 266
Singapore 250
Dublin 218
Dallas 207
San Jose 171
Ashburn 159
Moscow 144
Munich 123
Santa Clara 115
Chandler 113
Fairfield 96
Milan 91
Beijing 76
Council Bluffs 74
Hong Kong 66
Dong Ket 56
Ann Arbor 52
Helsinki 52
New York 44
Siena 44
Rome 40
Woodbridge 40
Los Angeles 38
Seattle 35
Hefei 34
Ho Chi Minh City 34
Jacksonville 33
Princeton 33
Lauterbourg 32
Seoul 31
Houston 30
Menlo Park 29
Wilmington 28
Johannesburg 27
Hanoi 24
Cambridge 21
Chennai 19
Málaga 19
Boardman 18
Columbus 18
The Dalles 17
London 16
Brussels 15
Buffalo 15
Shanghai 15
Dearborn 13
Düsseldorf 12
Frankfurt am Main 12
Perugia 12
San Mateo 12
São Paulo 12
Tokyo 12
Turku 12
Florence 11
Nanjing 11
Vienna 11
Naples 10
Nuremberg 10
Portsmouth 9
Chicago 8
Kampala 8
Memphis 8
Montreal 8
Redondo Beach 8
Bengaluru 7
Da Nang 7
San Francisco 7
Toronto 7
Warsaw 7
Washington 7
Addis Ababa 6
Amsterdam 6
Castel Volturno 6
Figino 6
Fremont 6
Orem 6
Abuja 5
Atlanta 5
Brooklyn 5
Denver 5
Guangzhou 5
Padua 5
Spring 5
Amman 4
Belo Horizonte 4
Bologna 4
Boston 4
Cagliari 4
Deiva Marina 4
Erbil 4
Grosseto 4
Izmir 4
Jyväskylä 4
Miami 4
Rio de Janeiro 4
San Diego 4
San José 4
Stockholm 4
Treviso 4
Turin 4
Totale 3.458
Salva come PNG Salva come JPEG
Nome #
UTILIZZO DI MILTEFOSINA IN PAZIENTE CON LEISHMANIOSI MUCOSA ED INFEZIONE DA HIV 587
"EFFICACY AND SAFETY OF 2-DRUG COMBINATION ANTIRETROVIRAL THERAPY IN CLINICAL PRACTICE: RESULTS FROM A SINGLE CENTER STUDY" 581
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 308
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 291
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 265
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 251
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: a cohort study 247
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 241
Use of Miltefosine in a Patient With Mucosal Leishmaniasis and HIV-coinfection: A Challenge in Long-Term Management 227
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: an ARCA cohort study 224
Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients – evidence from a large observational cohort 218
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: A multi-cohort study 198
Impact of resistance mutations on efficacy of dolutegravir plus rilpivirine or plus lamivudine as maintenance regimens: a cohort study 178
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: A retrospective study from the clinical practice 167
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects 164
Endocardite o non endocardite? Questo è il dilemma. 159
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 152
Simplification to High Genetic Barrier 2-Drug Regimens in People Living With HIV Harboring 4-Class Resistance Enrolled in the PRESTIGIO Registry 146
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view 139
Efficacia viro-immunologica dei regimi antiretrovirali duplici e triplici contenenti dolutegravir: risultati di uno studio di coorte 136
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort 132
Lack of HIV seroconversion in a patient treated immediately with antiretroviral therapy at acute infection and virus relapse 119
Sexually transmitted infections in people with multidrug-resistant HIV 115
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study 110
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors 88
Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy 18
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era 15
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort 14
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 14
All-Cause Mortality in People With Four-Class Drug-Resistant HIV: A Matched Cohort Analysis With Data From the PRESTIGIO Registry 13
Did the COVID-19 pandemic shift the landscape of late HIV diagnosis? 13
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500 000 copies/mL in 2018–2023 in Italy: data from the ICONA Foundation Cohort Study 13
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 12
Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: real-world data from the PRESTIGIO Registry 12
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry 10
Totale 5.577
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.762
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022258 0 0 16 23 17 13 19 18 34 20 30 68
2022/2023421 26 51 65 41 25 76 15 32 33 28 15 14
2023/2024435 12 8 38 28 20 114 125 16 2 15 29 28
2024/20251.063 19 31 81 33 136 105 108 82 121 46 108 193
2025/20262.171 185 211 188 311 492 76 238 71 61 137 74 127
2026/2027323 148 97 78 0 0 0 0 0 0 0 0 0
Totale 5.577